ARCHIVES

Two New Therapies For Metastatic Cancer Highlighted At AACR Annual Meeting

This article is from The Cancer Letter archive.

Vol. 26 No. 8 | August 29, 2003

Download PDF Visit The Full Archive

Related Articles

Aromasin Approved By FDA For ER+ Early Breast Cancer

October 28, 2005

Funding Opportunities

November 15, 2002

Ford Asks NCAB for Scientific Basis For Regulation Of Tar and Nicotine Content Of Cigarettes By Dec.

October 25, 1974

Presidents’ FY93 Budget Holds NCI To $2 Billion, Gives NIH 5% Increase; Coalition ‘Disapionted’

February 7, 1992

Rabson Recommended For NCI Acting Director, Will be Top Prospect For Permanent Appointment

August 26, 1988

Specific Pathology Pattern Can Predict Recurrence

August 30, 2013